Finnrick - Ensuring a Safer and More Transparent Supply Chain
HealthTide Biotech

HealthTide Biotech
Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP agonist) from HealthTide Biotech between 5 Aug 2025 and 26 Feb 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
C
OKAY
HealthTide Biotech
Tirzepatide
Tested 6 Samples
Last test 26 Feb 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from HealthTide Biotech

Samples are tested in commercial labs

Tests Count

6

Scores

AVG7.6MIN4.4MAX10.0

Last

26 Feb 2026

First

5 Aug 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
26 Feb 2026View10.030mg31.3mg+4.3%99.88%TR30No Label / Green Crimp / Pink CapLab EPublic
17 Dec 2025View9.410mg9.32mg-6.8%99.95%11/24/2025White Label / Silver Crimp / White CapLab EPublic
28 Aug 2025View8.030mg29.3mg-2.3%99.88%(no batch ID)No Label / Silver Crimp / Orange Cap Lab EPublic
28 Aug 2025View8.030mg29.2mg-2.7%99.89%(no batch ID)No Label / Silver Crimp / Red Cap Lab EPublic
5 Aug 2025View4.420mg16.9mg-15.5%86.05%Q368459261White Label / Silver Crimp / Gray Cap Lab EPublic
5 Aug 2025View6.120mg18.5mg-7.5%92.03%Q368459261White Label / Silver Crimp / Gray Cap Lab EPublic